Page 390 - Binder2

cognitive labor—like complex diagnostics,
longitudinal counseling, or care coordination.
• Hospitals and health systems design entire
business lines around biologic therapies, optimizing
scheduling, throughput, and drug markup to
maximize revenue per hour.

In this model, the drug is the draw, but the procedure is
the profit.

Edible Biologics Break the Model

Now introduce a therapy that:

• Requires no clinic visit.
• Is taken orally.
• Has minimal side effects.
• Can be grown locally or regionally, bypassing
specialty distributors.

There’s no infusion to bill for.
No nurse supervision to charge.
No facility fee to tack on.
No justification for $20,000 a dose—because the dose costs
a few dollars to grow and stabilize.

Suddenly, a practice built around volume-based billing
hits a wall.

The Reckoning: A New Financial Logic

This shift forces uncomfortable but essential questions:

388